Rubicon Organics has signed a product supply agreement with Canacur GmbH, a medical cannabis distributor incorporated in Nuremburg, Germany. "Pursuant to the Agreement, Canacur shall purchase dried cannabis from Rubicon Organics for an initial term of three years, with two optional two-year extensions available," the team with the company explains. "The Company expects first exports in the first half of 2021, pending EU-GMP certification."
“We are excited to bring our high-quality cannabis to German medical patients,” stated Jesse McConnell, CEO of Rubicon Organics. “This milestone agreement with Canacur provides another route to market and access to the fast-growing German medical market.”
"As part of the Agreement, Canacur has agreed to provide the Company up to $700,000 as advance payment for product, which will be secured behind existing secured lenders on the Company’s facility in Delta, British Columbia. This advance payment assists the Company to prepare for EU-GMP processing and certification."